MarketLens MarketLens
US: 2026-08-12 NSE: 2026-08-12 2026-08-12
Neutral
Menu

Stock Lookup

Search by symbol or company name, then inspect the chart and stock properties.

US

DAWN Day One Biopharmaceuticals, Inc.

TradingView As Of 4/24/26
Analyst Data
Refresh analyst earnings estimates and rating summary for this symbol only.
Close
21.5300
Day %
0.00%
RS
95
Ind Rank
#51
RS 1D
95
RS 1W
95
RS 1M
95
RS 3M
95
RS 6M
75
Consensus Rating
Hold
Current Quarter EPS
-0.31
Next Quarter EPS
-0.23
Current Year EPS
-0.86
Next Year EPS
0.01
ExchangeUS
Market Cap2 B
52W High21.5300
From 52W High0.00%
Open21.5300
High21.5300
Low21.5300
OptionsNo
ActiveNo
RS TypeFull
RS Date2026-06-24
Bars Available235
Scanner Hits45
Last Scanner Hit2026-06-24

Recent Scanner History

45 matching / 45 total
Reset
Date Scanner RS
2026-06-24 Extreme Contraction
US_EXTREME_CONTRACTION
95
2026-06-24 Doublers 6M
US_DOUBLERS_6M
95
2026-06-23 Extreme Contraction
US_EXTREME_CONTRACTION
95
2026-06-23 Doublers 6M
US_DOUBLERS_6M
95
2026-06-22 Extreme Contraction
US_EXTREME_CONTRACTION
95
2026-06-22 Doublers 6M
US_DOUBLERS_6M
95
2026-06-19 Extreme Contraction
US_EXTREME_CONTRACTION
95
2026-06-19 Doublers 6M
US_DOUBLERS_6M
95
2026-06-18 Extreme Contraction
US_EXTREME_CONTRACTION
95
2026-06-18 Doublers 6M
US_DOUBLERS_6M
95

Analyst Snapshot

As Of 3/29/26
Consensus Current Quarter EPS Next Quarter EPS Current Year EPS Next Year EPS
Hold -0.31 -0.23 -0.86 0.01
Based on 10 analysts offering recommendations for 'DAWN'.

Quarterly EPS Forecasts

5 rows
Period Consensus EPS High Low Estimates Revisions
Mar 2026 -0.31 -0.09 -1.04 7
0 3
Jun 2026 -0.23 -0.11 -0.28 5
0 3
Sep 2026 -0.22 -0.10 -0.30 5
0 0
Dec 2026 -0.22 -0.09 -0.43 5
0 0
Mar 2027 -0.18 -0.18 -0.18 1
0 0

Yearly EPS Forecasts

4 rows
Period Consensus EPS High Low Estimates Revisions
Dec 2026 -0.86 -0.16 -2.02 7
1 5
Dec 2027 0.01 1.20 -0.63 6
0 3
Dec 2028 -0.02 0.04 -0.06 3
0 0
Dec 2029 1.13 1.68 0.57 2
0 0